( March 7, 2025, 2:40 PM EST) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on March 6 affirmed a Virginia federal judge’s finding that a pharmaceutical company’s patent application for a treatment for ovarian and other cancers contains “‘fatally indefinite and obvious’” claims, nearly three years after the Federal Circuit vacated the judge’s grant of summary judgment against the company....